Advertisement

Infection

, Volume 25, Issue 5, pp 303–306 | Cite as

Antifungal activity of ketoconazole and other azoles againstMalassezia furfur in vitro andin vivo

  • V. Strippoli
  • A. Piacentini
  • F. D. D'Auria
  • N. Simonetti
Originalia

Summary

Thein vitro activity of several antifungal agents (ketoconazole, miconazole, econazole, fenticonazole, itraconazole, fluconazole) in routine clinical use againstMalassezia furfur infections has been studied with freshly isolated strains ofM. furfur from pityriasis versicolor lesions. The results indicate that the drugs tested exert a good activity, and both ketoconazole and itraconazole appear very active (0.8 mg/l respectively). Hair samples from the beards of volunteer patients affected by pityriasis versicolor but otherwise healthy were examined to determine ketoconazole levels during oral therapy (one or two 200 mg tablets daily). It was shown that the drug progressively accumulates in the beard, reaching levels proportional to the dose administered, although blood levels did not increase in parallel. The study of drug concentration profile has evidenced a long ketoconazole persistence in the beard at therapeutic levels. In conclusion, the possibility of reaching high and lasting ketoconazole levels in the keratin layer of the epidermis indicates that systemic ketoconazole therapy could be useful for eradication ofM. furfur in patients affected by pityriasis versicolor.

Keywords

Fluconazole Antifungal Activity Itraconazole Ketoconazole Azole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Faergemann, J. Pityrosporum ovale and skin diseases. Keio J. Med. 42 (1993) 91–104.Google Scholar
  2. 2.
    Faergemann, J., Djarv, L. Tinea versicolor treatment and prophylaxis and ketoconazole. Cutis 30 (1982) 542–545.Google Scholar
  3. 3.
    Jones, H. E. Ketoconazole today. A review of clinical experience. ADIS Press, Manchester 1987, pp. 45–48.Google Scholar
  4. 4.
    Faergemann, J. In Vitro andin vivo activities of ketoconazole and itraconazole againstPityrosporum orbiculare. Antimicrob. Agents Chemother. 26 (1984) 773–774.Google Scholar
  5. 5.
    Strippoli, V., Piacentini, A., D'Auria, F. D., Simonetti, N.: Sull'attività antifungina esercitata dal ketoconazolo versoPityrosporum sp. Atti del 25° Congresso Nazionale di Microbiologia, Alghero 27–30 Settembre 1995.Google Scholar
  6. 6.
    Barnett, J. A., Payne, R. W., Yarrow, D.: YEAST: characteristics and identification (2nd ed.). Cambridge University Press 1990, p. 425.Google Scholar
  7. 7.
    Galgiani, J. N. Susceptibility testing of fungi: current status of the standardization process. Antimicrob. Agents Chemother. 37 (1993) 2517–2521.Google Scholar
  8. 8.
    D'Auria, F. D., Simonetti, N., Strippoli, V. Increased itraconazole antifungal activity by agar diffusion test. J. Microb. Meth. 20 (1994) 47–54.Google Scholar
  9. 9.
    Roberts, S. O. B. Pityrosporum orbiculare: incidence and distribution of clinical normal skin. Br. J. Dermatol. 81 (1969) 264–269.Google Scholar
  10. 10.
    Rippon, J. W. Medical mycology, W. B. Saunders Company, Philadelphia 1988, pp. 154–159.Google Scholar
  11. 11.
    Klotz, S. A., Hupper, M., Drutz, D. J. Pulmonary vasculitis on intralipid therapy. N. Engl. J. Med. 306 (1982) 994–997.Google Scholar
  12. 12.
    Nenoff, P., Haustein, U. F. Der Effekt anti-seborrhoischer Substanzen gegenüberPityrosporum ovale “in vitro”. Hautarzt 45 (1994) 464–467.Google Scholar
  13. 13.
    Richardson, M. D., Shankland, G. Enhanced phagocytosis and intracellular killing ofPityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of yeast cell surface. Mycoses 34 (1991) 29–33.Google Scholar
  14. 14.
    Schewach-Millet, M., Kahana, M., Levy, A., Yaron-Schiffer, O., Sommer, B., Shalish, L. Ketoconazole an effective treatment for disseminated pityriasis versicolor. Isr. J. Med. Sci. 20 (1984) 417–419.Google Scholar
  15. 15.
    Epstein, E. H., Epstein, W. L. New cell formation in the human sebaceous gland. J. Invest. Dermatol. 46 (1966) 453–458.Google Scholar
  16. 16.
    Wright, N. A. The cell proliferation kinetics of the epidermis. In:Goldsmith, L. A. (ed.): Biochemistry and physiology of the skin. Oxford Press, New York 1983, pp. 203–229.Google Scholar
  17. 17.
    Harris, R., Jones, H. E., Artis, W. M. Orally administered ketoconazole: route of delivery to the human stratum corneum. Antimicrob. Agents Chemother. 24 (1983) 876–882.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1997

Authors and Affiliations

  • V. Strippoli
    • 1
  • A. Piacentini
    • 1
  • F. D. D'Auria
    • 2
  • N. Simonetti
    • 2
  1. 1.Institute of Microbiology, Faculty of Medicine and SurgeryRome
  2. 2.Institute of Microbiology, Faculty of PharmacyRomeItaly

Personalised recommendations